ClinicalTrials.Veeva

Menu

The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement

N

Negovsky Reanimatology Research Institute

Status

Enrolling

Conditions

Gonarthrosis
Osteo Arthritis Knee

Treatments

Procedure: Single-shot adductor canal block
Procedure: Continuous femoral nerve block

Study type

Interventional

Funder types

Other

Identifiers

NCT05487053
AdORe - ACB

Details and patient eligibility

About

Total knee replacement (TKR) is considered the most effective and safe method of radical treatment of late stages of knee osteoarthritis. A well-known problem of TKR is a severe postoperative pain syndrome, which is observed in more than 50% of patients.

Femoral nerve block (FNB) is the "gold standard" for continuous postoperative analgesia after total knee replacement, as it is effective in reducing the frequency of use of opioid analgetics and reduce the duration of hospitalization. At the same time, the negative effect of this method is the motor blockade of the quadriceps femoris muscle which leads to functional impairment and is associated with an increased risk of falling.

Adductor canal block (ACB) provides adequate analgesia comparable to femoral nerve block. Moreover, ACB doesn't affect the motor function of the quadriceps femoris muscle.

The possibility of enhanced recovery after total knee replacement is the reason to compare single-shot adductor canal block and continuous femoral nerve block.

Enrollment

220 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18
  • Planned primary total knee replacement
  • Planned neuraxial anesthesia
  • Written informed consent

Exclusion criteria

  • Urgent surgery
  • Planned revision total knee replacement
  • Known allergic reaction to anesthetics
  • Confirmed localized infection at the puncture sites
  • Confirmed localized tumor at the puncture sites
  • Peripheral neuropathy of the lower extremities
  • Parkinson's disease
  • Previously enrolled in this trial

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

220 participants in 2 patient groups

Single-shot adductor canal block
Experimental group
Treatment:
Procedure: Single-shot adductor canal block
Continuous femoral nerve block
Active Comparator group
Treatment:
Procedure: Continuous femoral nerve block

Trial contacts and locations

1

Loading...

Central trial contact

Valery Likhvantsev; Levan Berikashvili

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems